Nanologica
5,5 SEK -1,43%1 investor følger denne virksomhed
Nanologica is a biotechnology company that develops, manufactures, and sells nanoporous silica particles for life science applications. The company has two business areas: chromatography, which is an analysis and purification technique in the pharmaceutical industry used, for example in insulin, and drug development where the company develops an inhalation platform to deliver drugs locally in the lung. Nanologica was founded in 2004 and is headquartered in Södertälje.
Omsætning
1,44 mio.
EBIT %
-4.858,33 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
NICA
Daglig lav / høj pris
4,49 / 5,5
SEK
Markedsværdi
242,98 mio. SEK
Aktieomsætning
2,38 mio. SEK
Volumen
483 t
Finanskalender
Generalforsamling
16.05.2024
Delårsrapport
05.07.2024
Delårsrapport
25.10.2024
Årsrapport
07.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Flerie Invest AB | 41,2 % | 41,2 % |
Swedbank Robur Microcap | 6,4 % | 6,4 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Åsa Bergström New COO at Nanologica AB (publ)
Notice Convening the Annual General Meeting of Nanologica AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools